Aclaris Therapeutics (ACRS) Shares Issued (2016 - 2026)

Aclaris Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $57.9 million for Q1 2026.

• In Q1 2026, Shares Issued changed N/A year-over-year to $57.9 million; the TTM figure through Mar 2026 stood at $159.4 million (changed N/A YoY), while the FY2024 annual figure was $74.9 million, up 180.43% from the prior year.
• Shares Issued was $57.9 million for Q1 2026 at Aclaris Therapeutics, down from $74.9 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $74.9 million in Q4 2024 to a low of $37000.0 in Q1 2022.
• Historically, Shares Issued has averaged $38.7 million across 4 years, with a median of $42.3 million in 2023.
• Biggest YoY gain for Shares Issued was 100.08% in 2022; the steepest drop was 99.96% in 2022.
• A 4-year view of Shares Issued shows it stood at $72.6 million in 2022, then slumped by 63.26% to $26.7 million in 2023, then jumped by 180.62% to $74.9 million in 2024, then decreased by 22.7% to $57.9 million in 2026.
• The last three Shares Issued figures came in at $57.9 million (Q1 2026), $74.9 million (Q4 2024), and $26.7 million (Q3 2023), per Business Quant data.